Osteoarthritis Knee clinical trials

Explore recruiting osteoarthritis knee clinical trials.

Recruiting osteoarthritis knee studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Osteoarthritis Knee trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action study

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action study

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

LIPIOJOINT-2 : A randomized sham-controlled, double blind, multicenter trial on the effect of Genicular Arteries Embolization in symptomatic knee osteoarthritis

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

J1I-MC-GZBN:A Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants who have Obesity or Overweight and Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Trial

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

J1I-MC-GZBJ: A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1); J1I-MC-GOA1: Indication-Specific Appendix (ISA2) for participants with knee osteoarthritis (OA)

Romania, Poland, Hungary, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment of patellofemoral osteoarthritis with nasal chondrocyte-based engineered cartilage implantation in a randomized, controlled, multi-center phase II clinical trial

Germany, Croatia

Therapeutic exploratory (Phase II) EU CTIS Study details

Osteoarthritis Knee trials by city

Osteoarthritis Knee in Toronto Osteoarthritis Knee in Vancouver Osteoarthritis Knee in Montreal Osteoarthritis Knee in Calgary Osteoarthritis Knee in Edmonton Osteoarthritis Knee in Ottawa Osteoarthritis Knee in Winnipeg Osteoarthritis Knee in Quebec City Osteoarthritis Knee in Hamilton Osteoarthritis Knee in Kitchener Osteoarthritis Knee in London Osteoarthritis Knee in Halifax Osteoarthritis Knee in New York Osteoarthritis Knee in Los Angeles Osteoarthritis Knee in Chicago Osteoarthritis Knee in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease